Otsuka Holdings
4578.T
$40.01
Share price
-0.13%
Change (1 day)
20.29%
Change (1 year)
Categories
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.
EPS for Otsuka Holdings (4578.T)
EPS in 2023 (TTM): $2.43
According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is $2.43. In 2022 the company made an earnings per share (EPS) of $1.83 a decrease over its 2021 EPS that were of $2.09.
EPS history for Otsuka Holdings from 2010 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $2.43 | 32.62% |
| 2022 | $1.83 | -12.38% |
| 2021 | $2.09 | -18.58% |
| 2020 | $2.56 | 18.81% |
| 2019 | $2.16 | 55.85% |
| 2018 | $1.38 | -25.05% |
| 2017 | $1.85 | 10.15% |
| 2016 | $1.68 | 7.74% |
| 2015 | $1.56 | -39.2% |
| 2014 | $2.56 | -20.14% |
| 2013 | $3.21 | 51.58% |
| 2012 | $2.12 | -6.65% |
| 2011 | $2.27 | 29.28% |
| 2010 | $1.75 |